Essential Core Activities: NIAID Preclinical Development Support
$385,578N01FY2019AINIH
Advanced Bioscience Laboratories, Inc., Kensington MD
Investigators
Abstract
NIAID Preclinical Development Support: This contract will provide NIAID with a broad and flexible range of nontraditional, proactive and developmentally-oriented capabilities to provide preclinical development support for promising products when such products emerge from investigator-initiated research studies. These capabilities will allow NIAID to more rapidly and efficiently close development and production gaps. The Contractor shall assist NIAID staff in providing all support needed for small-scale production, preclinical testing and documentation leading to Investigational New Drug (IND) submission for Phase I, II, and III clinical testing
View original record on NIH RePORTER →